Study guide

15.1 Patient Care, Education, and Consent

Certified Nuclear Medicine Technologist CNMT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current CNMT Exam Facts 1.2 How to Use This Guide

2 Radiation Physics Fundamentals

2.1 Radioactive Materials, Isotopes, and Decay Modes 2.2 Decay Calculations and Counting Statistics 2.3 Interactions of Radiation with Matter 2.4 Radiation Detector Types and Principles

3 Biological Effects & ALARA

3.1 Biological Effects of Radiation Exposure 3.2 ALARA and Protection Calculations 3.3 Dose Limits, Surveys, and Personal Monitoring

4 NRC & Regulatory Compliance

4.1 NRC Areas, Spills, Waste, and Records 4.2 Written Directives and DOT Shipping 4.3 EPA, OSHA, HIPAA, FDA, and USP Standards 4.4 Radioactive Waste Disposal and Regulatory Records

5 Generators & Kit Preparation

5.1 Radionuclide Generators and Quality Control 5.2 Radiopharmaceutical Kit Preparation 5.3 Radiopharmaceutical Quality Control

6 Tc-99m Diagnostic Agents

6.1 Tc-99m Cardiac Imaging Agents 6.2 Tc-99m Bone, Renal, and GU Agents 6.3 Tc-99m GI and Hepatobiliary Agents 6.4 Tc-99m CNS, Infection, and Labeled Cells

7 Non-Tc Diagnostic & PET Agents

7.1 Iodine and Indium Diagnostic Agents 7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents 7.3 PET Radiopharmaceuticals 7.4 Neurologic, Breast, and Neuroendocrine PET Agents

8 Therapeutics, Adjuncts & Administration

8.1 Therapeutic Radiopharmaceuticals 8.2 Interventional and Adjunct Pharmaceuticals 8.3 Blood Labeling and Administration Techniques 8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents

9 Non-Imaging Instrumentation

9.1 Well Counters, Probes, and Survey Meters 9.2 Dose Calibrator Quality Control 9.3 Auxiliary and Patient Care Equipment

10 Imaging Systems & Quality Control

10.1 Gamma Camera Quality Control 10.2 SPECT and SPECT/CT Systems 10.3 PET and PET/CT Systems and QC 10.4 CT Systems, PACS, and Information Systems 10.5 CT Radiation Dose, Safety Alerts, and Protocol Optimization

11 Pulmonary, Bone, Oncology & Infection Imaging

11.1 Pulmonary Imaging Procedures 11.2 Bone and Musculoskeletal Imaging 11.3 Oncology Imaging Procedures 11.4 Infection Imaging Procedures

12 Renal, Endocrine & Hematopoietic Imaging

12.1 Renal and Genitourinary Imaging 12.2 Endocrine Imaging (Thyroid, Parathyroid, Adrenal) 12.3 Hematopoietic and Bone Marrow Imaging 12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

13 Cardiovascular Procedures

13.1 Myocardial Perfusion Imaging 13.2 Cardiac Function, Viability, and Special Studies 13.3 Exercise and Pharmacologic Stress Testing

14 GI, CNS, Therapy & Hybrid CT Procedures

14.1 Gastrointestinal Procedures 14.2 Central Nervous System Procedures 14.3 Radionuclide Therapy Procedures 14.4 CT and Hybrid Imaging in Nuclear Medicine 14.5 CSF Studies: Cisternography, Leak Localization, and Shunt Patency

15 Patient Care & Clinical Workflow

15.1 Patient Care, Education, and Consent 15.2 Scheduling and Radiopharmaceutical Procurement 15.3 Acquisition, Positioning, and Image Quality 15.4 Image Processing and Quantitative Analysis 15.5 Non-Imaging Studies: Specimens, Counting, and Error Analysis

15.1 Patient Care, Education, and Consent

Key Takeaways Explain This Topic AI

HIPAA requires minimum necessary use/disclosure of PHI; nuclear medicine technologists protect identity, images, reports, and spoken details in public areas, elevators, and waiting rooms.

Verify identity with at least two identifiers (armband + verbal name/DOB ± barcode scan) before every radiopharmaceutical administration, and reconcile the written/electronic order with the scheduled study and dose.

Pre-exam screening covers prep compliance, pregnancy/breastfeeding, contraindications, history, medications, allergies, recent contrast/procedures, and labs (e.g., creatinine before CT contrast; TSH/pregnancy when protocol requires).

Informed consent may be written or verbal per procedure risk and institutional policy; technologists educate on what happens, radiation precautions, activity restrictions, and therapy/inpatient release criteria—not medical diagnosis.

Emergency readiness includes recognizing syncope, seizure, and code responses; post-procedure assessment and correct biohazard disposal (sharps, blood, contaminated waste) close the care loop.

Last updated: August 2026

15.1 Patient Care, Education, and Consent

Quick Answer: Protect PHI (HIPAA) , confirm two patient identifiers , screen prep/contraindications/history/meds/allergies/labs , obtain or confirm informed consent , educate on procedure + precautions + release , and be ready for syncope, seizure, or code . Transfer safely, manage support devices (e.g., Foley), assess after the study, and dispose of biohazard/sharps correctly.

Clinical Procedures (Domain V) treats every study as a patient-care episode . CNMT items test the full sequence—from greeting through release—not only collimator choice.

HIPAA Privacy in the Nuclear Medicine Suite

The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule governs protected health information ( PHI ): names, medical record numbers, dates of birth, images, reports, appointment lists, and verbal details that can identify a patient.

  • Practice Why it matters
  • Discuss cases only with need-to-know staff Minimum necessary standard
  • Avoid hallway/elevator/waiting-room clinical talk Incidental disclosure risk
  • Log off workstations; face monitors away from public view Screen privacy
  • Release images/results only through authorized channels Patient rights + institutional policy
  • Shred or secure printed schedules with PHI Paper is still PHI

Nuclear medicine adds unique PHI vectors: hot-lab dose logs , camera worklists , and therapy written directives . Do not photograph identifiers on personal devices; de-identify teaching cases per policy.

Basic Patient Care: Vitals, First Aid, Infection Control

Technologists obtain or document vital signs when ordered or protocol-required (e.g., pharmacologic stress, therapy observation, unstable patients). Flag emergencies such as sudden hypotension after upright transfer, chest-pain tachycardia, or desaturation.

First aid / emergency recognition at the tech level:

Situation Immediate tech actions (high-level)

Fainting (syncope) Support patient to floor safely, protect head, elevate legs if appropriate, call for help, check responsiveness/breathing

Seizure Protect from injury, time the event, do not force objects into the mouth, recovery position when safe, activate emergency response

Code / unresponsiveness Call code team, begin BLS per training/certification, retrieve crash cart/AED, clear space for responders

Infection control: hand hygiene; standard precautions for all patients; transmission-based precautions as posted; disinfect camera surfaces, pads, and positioning aids between patients. Blood-borne pathogen spills follow institutional BBP procedures— not identical to a radioactive spill workflow (both may apply after a therapy accident).

Transfer Techniques and Support Devices

Safe transfer prevents falls and line disconnections. Assess mobility, use gait belts/slide boards when indicated, lock brakes, and never leave a fall-risk patient unattended on the table. For Foley catheters , keep the bag below bladder level , avoid kinks, and never rest it on the abdomen or detector. Keep IVs, oxygen, chest tubes, and drains patent during table motion—coordinate with nursing before disconnecting.

Patient Identification, Orders, and Pre-Exam Screening

Identification uses at least two identifiers —commonly armband name/MRN plus verbal full name and date of birth, often with barcode scan . Verify identity immediately before radiopharmaceutical administration, not only at check-in hours earlier.

Orders: confirm the electronic/written order matches the scheduled procedure, laterality/site when relevant, and authorized prescribing clinician. Question incomplete, conflicting, or outdated orders before drawing or administering activity.

Pre-exam screening checklist (exam favorites):

  • Screen item Examples / why
  • Prep compliance NPO, low-iodine diet, bowel prep, hydration, voiding

Contraindications Pregnancy for many studies; specific agent allergies; inability to lie flat for long SPECT when no alternative

  • History Prior NM studies, surgery, known disease, claustrophobia
  • Medications Interfering drugs (e.g., for MIBG, thyroid, cardiac stress protocols)
  • Allergies Contrast, latex, medications used as adjuncts

Labs / special status Creatinine/eGFR before IV CT contrast; pregnancy test; TSH status for thyroid cancer pathways

Recent procedures Iodinated contrast, barium, other tracers still on board

Document positive findings and escalate to the authorized user/physician when the study should be delayed, modified, or cancelled.

Informed Consent: Written vs Verbal

Informed consent means the patient (or legal surrogate) understands the procedure, material risks/benefits/alternatives at an appropriate level, and agrees voluntarily. Low-risk diagnostic exams often use verbal consent plus education; invasive procedures, research, and many therapeutic administrations require written consent (therapy also ties to written directives ).

Technologists confirm consent, answer logistics questions, and stop if consent is revoked or capacity is unclear—never pressure patients. Use plain language.

Education, Precautions, Restrictions, and Release Criteria

Teach what will happen (injection, wait, scan length, breath-holds), radiation precautions when applicable (hydration/voiding for bladder dose reduction; time/distance/hygiene after therapy), activity restrictions (driving after sedation, close contact with infants after high-activity therapy), and when to seek care (infiltrate symptoms, allergic reaction).

  • Setting Education focus
  • Outpatient diagnostic Timing, NPO if needed, post-void imaging, usual daily activity unless instructed
  • Inpatient Coordinate transport, lines, isolation status, nursing handoff of residual activity/precautions
  • Travel Airport/monitor letters for residual activity when policy provides them

Therapy (e.g., I-131) Home isolation rules, toilet hygiene, laundry, duration of restrictions, release criteria based on dose rate/activity rules

Release criteria after therapy follow NRC/agreement-state rules—technologists measure dose rates and document teaching, but the authorized user owns medical release decisions.

Post-Procedure Assessment and Biohazard Disposal

After imaging or therapy, reassess comfort, access sites, vitals when indicated, and ambulation. Report complications promptly. Dispose of sharps in puncture-resistant containers; bag blood-contaminated materials as biohazard; segregate radioactive waste per half-life and license rules—never mix ordinary trash with radioactive or infectious waste.

Bottom line: privacy + two identifiers + order/screen/consent + education + emergency readiness + clean disposal define safe CNMT-level patient care.